Apogee Enterprises is a leader in architectural products and services, providing architectural glass, aluminum framing systems and installation services for buildings, and value-added glass and acrylic for custom picture framing and displays. Its markets include the U.S. government, offices, education, health care and hotels. It operates under 4 segments. The Architectural Glass segment & The Architectural Services segment are involved in designing, engineering, fabricating and installing walls and windows of glass constituting the outside skin of commercial and institutional buildings. Its key products are Viracon & Harmon. The Architectural Framing Systems designs, engineers and finishes the aluminium frames for window, curtainwall, storefront and entrance systems with features like energy efficiency and hurricane protection. The segment comprises Wausau Window and Wall Systems, Tubelite and Linetec. The Large-Scale Optical segment manufactures value-added glass and acrylic products....
+See More2023-10-14 10:32:00 Saturday ET
Jonathan Baker frames the current debate over antitrust merger review and enforcement in America. Jonathan Baker (2019) The antitrust paradi
2020-02-26 09:30:00 Wednesday ET
Goldman Sachs follows the timeless business principles and best practices in financial market design and investment management. William Cohan (2011) M
2023-05-21 12:26:00 Sunday ET
Amy Chua and Jed Rubenfeld suggest that relatively successful ethnic groups exhibit common cultural traits in America. Amy Chua and Jed Rubenfeld (2015)
2018-05-06 07:30:00 Sunday ET
President Trump withdraws America from the Iran nuclear agreement and revives economic sanctions on Iran for better negotiations as western allies Britain,
2018-05-15 08:40:00 Tuesday ET
Net neutrality rules continue to revolve around the Trump administration's current IT agenda of 5G telecom transformation. Republican Senate passes the
2018-05-07 07:32:00 Monday ET
President Trump seeks to honor his campaign promise of lower U.S. medical costs by forcing higher big-pharma prices in foreign countries such as Canada, Bri